Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 5 | O'Brien Michael GrahamCFO | GTMZoomInfo Technologies Inc. Option exercise | M | — 1,542 sh | Nov 3, 2026 |
| 5 | Potts Charles EdwardDirector |  IDAIT Stamp IncGrant or award | A | — 1,034 sh | Nov 3, 2026 traded Oct 31, 2026 |
| 5 | Comer James FDirector | NONEWILSON BANK HOLDING CO Option exercise | M | — 5,000 sh | Nov 3, 2026 traded Nov 3, 2026 |
| 5 | Comer James FDirector | NONEWILSON BANK HOLDING CO Option exercise | M | — 5,000 sh | Nov 3, 2026 traded Nov 3, 2026 |
| 5 | Melwani PraveerCFO and Treasurer | FIGFigma, Inc. Tax withholding | F | $242K 11.2K sh | Nov 3, 2026 traded Nov 1, 2026 |
| 5 | Maddison John AnthonyChief Product Mkting Officer |  FFIVF5, INC.Grant or award | A | — 4,265 sh | Nov 3, 2026 traded Nov 2, 2026 |
| 5 | Ellingson Alan WayneChief Financial Officer |  DKNGDraftKings Inc.Tax withholding | F | $44K 2,084 sh | Nov 3, 2026 traded Nov 1, 2026 |
| 4 | Moat RossCHIEF OPERATING OFFICER |  KNSAKiniksa Pharmaceuticals International, plcOption exercise · 10b5-1 plan | M | — 12.3K sh | Nov 3, 2026 traded Nov 2, 2026 |
| 4 | Moat RossCHIEF OPERATING OFFICER | KNSAKiniksa Pharmaceuticals International, plc Option exercise · 10b5-1 plan | M | — 9,412 sh | Nov 3, 2026 traded Nov 2, 2026 |
| 4 | Trivedi SurekhaSVP, Strategy & Sustainability |  VLTOVeralto CorpOption exercise · 10b5-1 plan | M | $1.27M 26.5K sh | Nov 3, 2026 traded Oct 30, 2026 |
| 4 | Skinner Todd C.President, International |  TRUTransUnionOpen-market sale · 10b5-1 plan | SELL | $78K 1,000 sh | Nov 3, 2026 traded Nov 2, 2026 |
| 3 | Armagno NinaDirector | RKLBRocket Lab Corp Open-market sale · 10b5-1 plan | SELL | $5,501 100 sh | Nov 3, 2026 traded Nov 2, 2026 |
| 3 | Powell RikkiChief Financial Officer |  SSTKShutterstock, Inc.Option exercise · 10b5-1 plan | M | — 3,635 sh | Nov 3, 2026 traded Nov 1, 2026 |
| 3 | Powell RikkiChief Financial Officer | SSTKShutterstock, Inc. Tax withholding · 10b5-1 plan | F | $8,313 2,008 sh | Nov 3, 2026 traded Nov 1, 2026 |
| 2 | Ohlgart ChristianeChief Financial Officer |  FTNTFortinet, Inc.Option exercise | M | — 301 sh | Nov 3, 2026 traded Nov 1, 2026 |
| 2 | Razzaghi HosseinChief Commercial Officer | CRCLCircle Internet Group, Inc. Tax withholding · 10b5-1 plan | F | $125K 1,717 sh | Nov 3, 2026 traded Nov 1, 2026 |
| 2 | Allaire JeremyDirector, Chairman and CEO | CRCLCircle Internet Group, Inc. Option exercise | M | — 6,017 sh | Nov 3, 2026 traded Nov 1, 2026 |
| 2 | Werner Edward CooperChief Financial Officer | FFIVF5, INC. Grant or award | A | — 5,611 sh | Nov 3, 2026 traded Nov 2, 2026 |
| 2 | Allaire JeremyDirector, Chairman and CEO | CRCLCircle Internet Group, Inc. Option exercise | M | — 15.2K sh | Nov 3, 2026 traded Nov 1, 2026 |
| 2 | Moat RossCHIEF OPERATING OFFICER | KNSAKiniksa Pharmaceuticals International, plc Option exercise · 10b5-1 plan | M | $197K 10.9K sh | Nov 3, 2026 traded Oct 30, 2026 |
| 2 | Montoya Michael FChief Technology Ops Officer | FFIVF5, INC. Grant or award | A | — 3,928 sh | Nov 3, 2026 traded Nov 2, 2026 |
| 2 | Schulz Tamara LChief Accounting Officer | CRCLCircle Internet Group, Inc. Tax withholding · 10b5-1 plan | F | $75K 1,030 sh | Nov 3, 2026 traded Nov 1, 2026 |
| 1 | Hathi NeeshaMD, Head Wealth Adv, Bnk, Tst |  SCHWSCHWAB CHARLES CORPOption exercise · 10b5-1 plan | M | $321K 5,000 sh | Nov 3, 2026 traded Nov 2, 2026 |
| 1 | Fox-Geen JeremyChief Financial Officer | CRCLCircle Internet Group, Inc. Tax withholding · 10b5-1 plan | F | $281K 3,877 sh | Nov 3, 2026 traded Nov 1, 2026 |
| 1 | Clements Carol AnnChief Digital & Tech Officer |  JBLUJETBLUE AIRWAYS CORPOpen-market sale · 10b5-1 plan | SELL | $5,920 2,000 sh | Nov 3, 2026 traded Oct 30, 2026 |
| 1 | Trivedi SurekhaSVP, Strategy & Sustainability | VLTOVeralto Corp Option exercise · 10b5-1 plan | M | $376K 9,907 sh | Nov 3, 2026 traded Oct 30, 2026 |
| 0 | Moat RossCHIEF OPERATING OFFICER | KNSAKiniksa Pharmaceuticals International, plc Option exercise · 10b5-1 plan | M | $143K 6,263 sh | Nov 3, 2026 traded Nov 2, 2026 |
| 0 | Enguent Jean-PierreVice President, R&DSS |  LAESSEALSQ CorpGrant or award · 10b5-1 plan | A | — 50.0K sh | Nov 3, 2026 traded Nov 2, 2026 |
| 0 | Enguent Jean-PierreVice President, R&DSS | LAESSEALSQ Corp Option exercise · 10b5-1 plan | M | — 15.0K sh | Nov 3, 2026 traded Nov 2, 2026 |
| 0 | Enguent Jean-PierreVice President, R&DSS | LAESSEALSQ Corp Option exercise · 10b5-1 plan | M | $150 15.0K sh | Nov 3, 2026 traded Nov 2, 2026 |
| 0 | McGrane AshleyGeneral Counsel and Corp Sec | GTMZoomInfo Technologies Inc. Option exercise · 10b5-1 plan | M | — 5,987 sh | Nov 3, 2026 traded Nov 1, 2026 |
| 0 | McGrane AshleyGeneral Counsel and Corp Sec | GTMZoomInfo Technologies Inc. Tax withholding · 10b5-1 plan | F | $13K 2,895 sh | Nov 3, 2026 traded Nov 1, 2026 |
| 0 | Chandrasekhar Rao JadcherlaSVP, Products and Services |  EGANEGAIN CorpOption exercise · 10b5-1 plan | M | — 6,000 sh | Nov 3, 2026 traded Nov 2, 2026 |
| 0 | Hathi NeeshaMD, Head Wealth Adv, Bnk, Tst | SCHWSCHWAB CHARLES CORP Option exercise · 10b5-1 plan | M | — 5,000 sh | Nov 3, 2026 traded Nov 2, 2026 |
| 0 | Spice Adam C.Chief Financial Officer | RKLBRocket Lab Corp Option exercise · 10b5-1 plan | M | $153K 140.2K sh | Nov 3, 2026 traded Nov 2, 2026 |
| 0 | Moat RossCHIEF OPERATING OFFICER | KNSAKiniksa Pharmaceuticals International, plc Option exercise · 10b5-1 plan | M | $22K 1,658 sh | Nov 3, 2026 traded Oct 30, 2026 |
| 0 | Moat RossCHIEF OPERATING OFFICER | KNSAKiniksa Pharmaceuticals International, plc Option exercise · 10b5-1 plan | M | — 16.1K sh | Nov 3, 2026 traded Oct 30, 2026 |
| 0 | Moat RossCHIEF OPERATING OFFICER | KNSAKiniksa Pharmaceuticals International, plc Option exercise · 10b5-1 plan | M | — 21.1K sh | Nov 3, 2026 traded Oct 30, 2026 |
| 0 | Moat RossCHIEF OPERATING OFFICER | KNSAKiniksa Pharmaceuticals International, plc Option exercise · 10b5-1 plan | M | — 3,760 sh | Nov 3, 2026 traded Oct 30, 2026 |
| 0 | McGrane AshleyGeneral Counsel and Corp Sec | GTMZoomInfo Technologies Inc. Open-market sale · 10b5-1 plan | SELL | $3,285 773 sh | Nov 3, 2026 traded Nov 3, 2026 |
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
BBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
BCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K